Zimbabwe becomes the first African country to authorize use of COVID 19 vaccine ‘COVAXIN’. Zimbabwe has reported over 36,000 coronavirus cases and 1,478 death due to the virus so far.
“Zimbabwe has authorized the use of COVAXIN, India’s indigenous COVID-19 vaccine, becoming the first country in Africa to do so. Trying to get it to Zimbabwe at an early date,” tweeted Indian Embassy in Zimbabwe.
Bharat Biotech, a global leader in vaccine innovation, developed India’s first COVID-19 Vaccine which demonstrated interim clinical efficacy of 81%. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research.
